Arkolith/Insider Trading/DSGN/Form 4

Siffert Joao MD

President and CEO, DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Dec 21, 2022
Net Buying
Open-Market Buys
$63K
Open-Market Sells
$0
Net Open-Market Flow
$63K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2022Buy(P)6K$8.38$53K133K
Dec 19, 2022Buy(P)1K$8.47$10K126K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-062349) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML